Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Julia, Dudnik"'
Autor:
Ari Raphael, Amir Onn, Liran Holtzman, Julia Dudnik, Damien Urban, Waleed Kian, Aharon Y. Cohen, Mor Moskovitz, Alona Zer, Jair Bar, Natalie Maimon Rabinovich, Shirly Grynberg, Cecilie Oedegaard, Abed Agbarya, Nir Peled, Tzippy Shochat, Elizabeth Dudnik
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe use of CGP in guiding treatment decisions in aNSCLC with acquired resistance to ALK TKIs is questionable.MethodsWe prospectively assessed the impact of CGP on the decision-making process in ALK-rearranged aNSCLC patients following progr
Externí odkaz:
https://doaj.org/article/f85c5c5f27684af1b3b0753d584f245f
Autor:
Elizabeth Dudnik, Jair Bar, Assaf Moore, Teodor Gottfried, Mor Moskovitz, Julia Dudnik, Tzippy Shochat, Aaron M. Allen, Alona Zer, Ofer Rotem, Nir Peled, Damien Urban
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesLittle is known regarding the outcomes of systemic treatments in BAP1-altered malignant pleural mesothelioma (MPM).Materials and MethodsForty five patients with MPM [group A: eight MPM patients with BAP1 inactivating mutation/copy number lo
Externí odkaz:
https://doaj.org/article/3a22bf6714734771a3834ddc2e05cc4b
Autor:
Gad Rennert, Maya Gottfried, Hedy S Rennert, Flavio Lejbkowicz, Meira Frank, Ilana Cohen, Shiri Kelt, Abed Agbarya, Elizabeta Dudnik, Julia Dudnik, Rivka Katznelson, Moshe Mishali, Natalie Maimon Rabinovich, Hovav Nechushtan, Amir Onn, Shoshana Keren Rosenberg, Mariana Wollner, Alona Zer, Jair Bar, Naomi Gronich
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100934- (2021)
Purpose: A substantial fraction of all non-small cell lung cancers(NSCLC) carry a mutation in the EGFR gene for which an effective treatment with anti-tyrosine kinases(TKIs) is available. We studied the long term survival of these patients following
Externí odkaz:
https://doaj.org/article/26a31ca9e38842c584e0074d2e96db7d
Autor:
Nir Peled, Laila C. Roisman, Esther Levison, Julia Dudnik, Elena Chernomordikov, Norman Heching, Elizabeth Dudnik, Shoshana Keren-Rosenberg, Hovav Nechushtan, Ayman Salhab, Dov Hershkovitz, Shlomo Tsuriel, Victoria Hannes, Ofer Rotem, Irina Lazarev, Rachel Lichtenberg, Inbal S. Granot, Bilal Krayim, Walid Shalata, Daniel Levin, Yanay Krutman, Aaron M. Allen, Philip Blumenfeld, Konstantin Lavrenkov, Waleed Kian
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4d8ba0c99a1de1e6dfc3b6fbad06e71
https://doi.org/10.1016/j.ijrobp.2023.03.042
https://doi.org/10.1016/j.ijrobp.2023.03.042
Publikováno v:
Clinical Nuclear Medicine. 44:e540-e543
Epithelioid hemangioendothelioma is a rare low- to intermediate-grade malignant vascular neoplasm with a variable clinical course and currently no standardized treatment. We present a case of a 65-year-old woman diagnosed as having mediastinal epithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47dae1f29ce99942a30b0e6f2569b805
https://doi.org/10.1097/rlu.0000000000002726
https://doi.org/10.1097/rlu.0000000000002726
Autor:
Jair, Bar, Marina, Perelman, Damien, Urban, Maya, Gottfried, Mor, Moskovitz, Hovav, Nechushtan, Julia, Dudnik, Alona, Zer, Elizabeth, Dudnik, Ofer, Merimsky, Amir, Onn, Barbara, Silverman
Publikováno v:
The Israel Medical Association journal : IMAJ. 22(12)
Lung cancer is the most common cause of cancer-related death.To identify changing patterns of lung cancer and its histologic subtypes among different population groups in Israel over a 25 year period.Primary lung cancers, all types and all stages, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21ab772a987d3ac3117feae13ca18514
https://pubmed.ncbi.nlm.nih.gov/33381954
https://pubmed.ncbi.nlm.nih.gov/33381954
Autor:
Lior Soussan-Gutman, L. Roisman, Levin Daniel, Waleed Kian, Vered Fuchs, R. Grinberg, Iris M Goldstein, Julia Dudnik, Hovav Nechushtan, Roni Gillis, Nir Peled, Addie Dvir
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 153
Background Resistance mechanisms following 1st line therapy with osimertinib in EGFR + NSCLC have become focus of investigation. This retrospective study aims to deepen the understanding and clarify possible mechanisms of osimertinib 1st line resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319a404627966f05aedc46d80b5baaac
https://pubmed.ncbi.nlm.nih.gov/33486418
https://pubmed.ncbi.nlm.nih.gov/33486418
Autor:
Iris M Goldstein, Julia Dudnik, L. Roisman, Waleed Kian, Shoshana P. Keren-Rosenberg, Ilan Shelef, Nir Peled, Vered Fuchs, Hovav Nechushtan
Publikováno v:
Neuro-oncology Advances
Background Osimertinib is a selective irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) with increased penetration across the blood–brain barrier compared with previous EGFR-TKIs, and thus, a 52% reduction in the ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908094825f2e8f666be5c74e0f5e46b4
https://doi.org/10.1093/noajnl/vdaa125
https://doi.org/10.1093/noajnl/vdaa125
Autor:
Talia Golan, Talia Shentzer Kutiel, Maya Gottfried, Alona Zer, Aviad Zick, Ayelet Shai, Larissa Ryvo, Julia Dudnik, Nir Peled, Galia Oberkovitz, Fan Yang, Shmuel Sharoni, Changting Meng, Dayana Michel, Eric Sbar, Jatin J. Shah, Michael Kauffman, Sharon Shacham, Ravit Geva
Publikováno v:
Journal of Clinical Oncology. 40:110-110
110 Background: Single agent selinexor, an oral selective inhibitor of nuclear export (SINE), showed activity against heavily pretreated CRC with RAS mutations (mut) or wildtype (wt) in 2 clinical studies. In preclinical studies, selinexor showed sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d402b6e574cc99a54be05b5ec247048b
https://doi.org/10.1200/jco.2022.40.4_suppl.110
https://doi.org/10.1200/jco.2022.40.4_suppl.110
Publikováno v:
Clinical Nuclear Medicine. 44:815-817
Ga-DOTATATE imaging is commonly used for the detection of metastatic disease in neuroendocrine tumors. We present a case of a 69-year-old woman postsurgery for lung carcinoid tumor in which sequential follow-up Ga-DOTATATE PET/CT studies identified f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cad656593970c870f0f29efe820d3a9
https://doi.org/10.1097/rlu.0000000000002746
https://doi.org/10.1097/rlu.0000000000002746